Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q1 FY24 Earnings Presentation
22 slides from Apollo Hospitals Enterprise's earnings presentation, Aug 11, 2023
Slide 1: Regulation 30 disclosure letter to stock exchanges
.~ l~ono APOLLO HOSPITALS ENTERPRISELIMITED l?osPITALS CIN:L85110TN1979PLC008035 August 11, 2023 The Secretary, The Secretary, The Manager Bombay Stock Exchange Ltd (BSE) National Stock Exchange, The National Stock Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Exchange, Dalal Street, Plot N
Slide 2: Earnings Update Q1 FY24
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q1 FY24
Slide 3: Highlights
HIGHLIGHTS 2
Slide 4: Key Highlights
Key Highlights 01 Highlights 02 Financials 03 Healthcare Services 04 05 Digital Health 06 Annexure Diagnostics & Retail Health & Pharmacy Distribution 3
Slide 5: Highlights Q1FY24: Operational
Highlights Q1FY24 : Operational Healthcare Services 43 Owned 9,445 133,846 (Hospitals) + 62% ` 57,760 / day Owned & In-patients 6 Managed Managed Occupancy ARPOB1 Hospitals Beds Diagnostics & 22 Retail Health Ambulatory 576 2,012 350 119 133 care & Birthing Beds Diagnostics Clinics Dialysis Dental C
Slide 6: Clinical Updates
o Apollo Hospitals leads India’s Solid Multi-Organ Transplantation with over 23,000 transplants, establishes global leadership. o Apollo expands its dedicated Robotic Colorectal Surgery Programme across 6 cities – Chennai, Hyderabad, Bangalore, Delhi, Mumbai and Vishakhapatnam. Apollo’s collective r
Slide 7: Highlights Q1FY24: Financials
Highlights Q1FY24 : Financials Revenue Growth EBITDA1 Growth EBITDA1 PAT Growth (in ₹ Mio) YoY(%) (in ₹ Mio) YoY(%) Margin (%) (in ₹ Mio) YoY(%) Healthcare Services 22,937 13% 5,423 12% 23.6% 2,639 19%2 Offline PD^ 16,001 18% 1,250 13% 7.8% Health Co (566) (826) NA Online PD^ & (1816) 2,053 70% NA 2
Slide 8: Financials: Consolidated
Financials Consolidated 7
Slide 9: Consolidated Financials Q1 FY24
Consolidated Financials Q1 FY24 Digital Health Healthcare Diagnostics & ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 22,937 3,187 18,054 44,178 EBITDA (Pre 24|7 Cost) 5,423 233 1,473 7,129 margin (%) 23.6% 7.3% 8.2% 16.1% 24/7 Operating Cost -1,747 -1,747 ESOP(Non Cash
Slide 10: Healthcare Services: Hospitals
Healthcare Services Hospitals 9
Slide 11: Consolidated Healthcare Services Performance Q1FY24
Consolidated Healthcare Services Performance Q1FY24 Healthcare Serv ` Mio No of Hospitals Operating beds Healthcare Serv Group (Mature) 29 5418 Group (New & Others) 14 2380 Healthcare Serv Group 43 7798 - HCS Revenue grew by 13% (Volume growth 6%, price and case mix of 7%) and EBITDA grew by 12% in
Slide 12: Region wise Operational Parameters
Region wise Operational Parameters Tamilnadu Region AP, Telengana Region (Hyderabad Particulars No. of Operating beds Inpatient volume Q1 FY 23 7,864 126,511 Total (6) Q1 FY 24 7,798 133,846 yoy (%) 5.8% (Chennai & others) (1) Q1 FY 23 2,156 33,952 Q1 FY 24 2,088 35,246 yoy (%) 3.8% 1,297 17,675 & o
Slide 13: Diagnostics & Retail Health
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 12
Slide 14: Executive Summary
Executive Summary • Selective network additions being planned in key metro markets (viz. Bangalore, Chennai, Delhi NCR, Hyderabad) • Focus on creating distinguished end to end out patient experience Primary Care • Corporate empanelment via customized portals for better utilization of employee benefi
Slide 15: Financial Performance Q1FY24
Financial Performance Q1FY24 Q1 FY24 Network Footfalls/Day* Clinics 350 2,258 Diagnostics 2,012 14,106 Sugar 65 472 Dental 133 223 Dialysis 119 1,850 Cradles (IP) 10 46 IVF 17 39 Spectra (IP) 11 72 - AHLL Core Revenues (excluding Covid Vaccination, Covid Testing and Isolation Centre Revenues which w
Slide 16: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn)1 EBITDA (INR Mn)2 Operational footprint (as of Jun 30, 2023) 1,040 1,031 1,075 940 16 816 118 24 15 14% ~260 99 Cities 5% 7% 1,059 148 presence 922 916 1,016 5% 5% 75 717 39 51 50 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q1 FY23 Q2 FY23 Q3 FY23 Q4 F
Slide 17: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution Apollo Health Co 16
Slide 18: India's Largest Omni-Channel Healthcare
India’s Largest Omni-Channel Healthcare Apollo 247 –Digital Platform Apollo Pharmacy Platform Added As at June 30, 2024 Q1 24 43 ~27 Mn+ ~8.5 Lakh ~6,000+ Closed 11 Registrations Daily Active Users Doctors Q1 24 -----, - Net 32 (I) Chandigarh: 5 r • -•· Doctor Consultation Daily Consultation 9,500+
Slide 19: Health Co Financials Q1 FY24
Health Co Financials Q1 FY24 Online Pharmacy Offline Pharmacy Total Health ` Mio Distribution & Distribution Co Omnichannel Pharmacy: Apollo 247 Total Revenues 16,001 2,053 18,054 o Omnichannel Pharmacy Business revenue of Rs 22,464 Mn in Q1’ FY24 compared to EBITDA* 1,250 223 1,473 a revenue of Rs
Slide 20: Annexure
Annexure 19
Slide 21: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarpet - Chennai Chennai Apollo Hea
Slide 22: Thank you!
Thank you ! 21
Apollo Hospitals Enterprise — Q1 FY24 Earnings Presentation on 6ix